{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/nappy-rash/","result":{"data":{"firstChapter":{"id":"6bd868d7-97dc-5abb-9dd7-5bd8d9a45b42","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 64e7e825-62da-44c6-81a6-3f067090f021 --><h1>Nappy rash: Summary</h1><!-- end field 64e7e825-62da-44c6-81a6-3f067090f021 -->","htmlStringContent":"<!-- begin item 3bce4d77-99cd-48a6-ae4c-345eb5d575cf --><!-- begin field ae67bc0c-51fb-46e1-9106-a02d5699c78a --><ul><li>Nappy rash is an acute inflammatory reaction of the skin in the nappy area, which is most commonly caused by an irritant contact dermatitis. It is also known as 'napkin dermatitis' or 'diaper dermatitis'.<ul><li>The skin barrier function can be compromised by skin maceration, friction, prolonged skin contact with urine and faeces, and resultant increased skin pH.</li><li>Complications include secondary infection with Candida and bacteria such as Staphylococcus aureus and streptococci.</li></ul></li><li>It is estimated that nappy rash affects up to 25% of nappy-wearing infants at any given time.</li><li>Risk factors include the skin cleaning regime, type of nappy, use of baby wipes and other topical preparations, and recent diarrhoea or antibiotic use.</li><li>A diagnosis of nappy rash should be suspected if there are typical clinical features:<ul><li>The child may appear distressed, agitated, or uncomfortable, as the rash may be itchy and painful.</li><li>Well-defined areas of confluent erythema and scattered papules over convex surfaces in contact with the nappy (the buttocks, genitalia, suprapubic area, and upper thighs), with sparing of the inguinal skin creases and gluteal cleft.</li><li>There may be skin erosions, oedema, and ulceration if there is severe involvement.</li></ul></li><li>Assessment of a child with suspected nappy rash should include:<ul><li>Asking about the location, nature, and duration of rash; any previous episodes; and any treatments, such as barrier preparations.</li><li>Examining for oral candidiasis and features which may suggest candidal or bacterial secondary infection, especially if the rash is severe.</li><li>Considering taking a skin swab for culture and sensitivity, if secondary bacterial infection is suspected.</li></ul></li><li>Management of nappy rash includes:<ul><li>Advising the parents/carers on self-management strategies, such as using a nappy with high absorbency; leaving nappies off for as long as possible; changing the nappy frequently and as soon as possible after wetting or soiling; using water, or fragrance- and alcohol-free baby wipes; drying gently after cleaning; avoiding potential irritants such as soaps and bubble bath.</li><li>Advising on sources of written information and support.</li><li>Use of a barrier preparation to protect the skin, if there is mild erythema and the child is asymptomatic.</li><li>Prescribing topical hydrocortisone 1% cream once a day in addition, if the rash appears inflamed and is causing discomfort.</li><li>Prescribing a topical imidazole cream, if the rash persists and candida infection is suspected or confirmed on swab.</li><li>Prescribing oral antibiotics, if the rash persists and bacterial infection is suspected or confirmed on swab.</li><li>Arranging to review the child, the time interval depending on clinical judgement, to assess the response to treatment.</li></ul></li><li>If initial treatment is unsuccessful, any underlying cause of treatment failure should be managed, such as:<ul><li>Non-adherence to skin care advice or the treatment regimen.</li><li>Candidal or bacterial secondary infection.</li><li>An alternative cause for the rash.</li></ul></li><li>Referral to a paediatric dermatologist should be considered if:<ul><li>There is uncertainty about the diagnosis.</li><li>The rash persists despite optimal treatment in primary care.</li><li>There are recurrent, severe unexplained episodes.</li></ul></li></ul><!-- end field ae67bc0c-51fb-46e1-9106-a02d5699c78a --><!-- end item 3bce4d77-99cd-48a6-ae4c-345eb5d575cf -->","topic":{"id":"fced145b-8234-5cd6-8495-21dd435fa09e","topicId":"bf5cc007-7a69-42da-9cce-026e01ec0830","topicName":"Nappy rash","slug":"nappy-rash","aliases":[],"chapters":[{"id":"6bd868d7-97dc-5abb-9dd7-5bd8d9a45b42","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"285ad030-4a43-587e-b95d-111b05082bd7","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"51cba348-0401-515c-b0cb-403accf300bb","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"3faf55b7-5b1b-55f9-87fa-6c77ae443435","slug":"changes","fullItemName":"Changes"},{"id":"5d2e0f7f-32f0-515c-acf8-f41a7793f377","slug":"update","fullItemName":"Update"}]},{"id":"6afe2031-7d04-5d34-8f93-9f76b0cee31f","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"df2b7ca6-faa1-5155-b6f8-e38e875710a9","slug":"goals","fullItemName":"Goals"},{"id":"c88d8b1e-a003-5fdb-8125-60256108c8fd","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2381dd75-9264-51ce-923a-ffd47d06fb70","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9148277c-7b69-5abd-96e6-6da6cdc0692c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e337d403-433f-5884-ad90-0dc4725b9e10","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"98137183-55d3-54da-8a82-f70edd211099","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2308d842-41bc-5c6e-b14f-7a732380baae","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"25c232ac-1d36-5623-a083-670842228d71","slug":"definition","fullItemName":"Definition"},{"id":"d6bc684b-0cf9-51f4-880a-68386599241c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0baab6c3-f7e8-573b-96ee-4e51d9cb5330","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"8e6a2c35-a2df-5ed9-8430-1d28fa50879e","slug":"complications","fullItemName":"Complications"},{"id":"808d9af1-4926-59a3-80ef-e810780e9314","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"34a7e7aa-63d3-5df0-9b78-2d694441515e","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"0f83f809-aed6-51e2-990d-c63ccf224d4e","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"36a8ef6d-dd7b-5e24-88b6-2e0d2e428522","slug":"assessment","fullItemName":"Assessment"},{"id":"da38cadb-36b7-5e94-a4d2-1ac880a9fc14","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"512f5f04-323c-5417-9d49-118aaf08ef60","slug":"management","fullItemName":"Management","subChapters":[{"id":"e22f1fdc-9a01-51a6-9519-694c4dc68f3e","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"919d8121-c385-56c1-a44a-d1b60e0744d8","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"54149fa7-c48e-56d7-909c-d76fceaaa0b6","slug":"topical-imidazoles","fullItemName":"Topical imidazoles"},{"id":"3e0033c5-591d-5608-8277-0cb6706398f5","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"4a82e127-a2d6-5fae-9103-e83494a28d24","slug":"clarithromycin","fullItemName":"Clarithromycin"}]},{"id":"01431b56-1a68-53cb-9666-0bc883bec5ff","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"186815e3-961f-5ab5-b89d-b7d341d8851a","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"c9ab642f-9b46-54ff-a595-1e9168cbfdff","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a12c552f-6d1a-5409-a5cf-dc1efba7bb2a","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d9167d23-de60-534b-b0da-c093d3a37b23","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"33ede077-9ff7-58b7-981d-d4dd371561b0","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"db7928f1-0104-5ed1-8880-c59b9f060e6f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"96311897-ae0a-5de9-a6a0-0cb5e181a4d3","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"fced145b-8234-5cd6-8495-21dd435fa09e","topicId":"bf5cc007-7a69-42da-9cce-026e01ec0830","topicName":"Nappy rash","slug":"nappy-rash","aliases":[],"topicSummary":"Nappy rash is an irritant contact dermatitis confined to the nappy area. Colonization with Candida albicans is usual.","lastRevised":"Last revised in September 2020","nextPlannedReviewBy":"2023-07-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2023-06","nextPlannedReviewByDisplay":"June 2023","specialities":[{"id":"e9e3ea2b-52b8-5242-bc9d-24052ea8647a","name":"Child health","slug":"child-health"},{"id":"50071c38-ab10-5ab8-ac70-6bd19a96c24e","name":"Skin and nail","slug":"skin-nail"}],"chapters":[{"id":"6bd868d7-97dc-5abb-9dd7-5bd8d9a45b42","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"285ad030-4a43-587e-b95d-111b05082bd7","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"51cba348-0401-515c-b0cb-403accf300bb","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"3faf55b7-5b1b-55f9-87fa-6c77ae443435","slug":"changes","fullItemName":"Changes"},{"id":"5d2e0f7f-32f0-515c-acf8-f41a7793f377","slug":"update","fullItemName":"Update"}]},{"id":"6afe2031-7d04-5d34-8f93-9f76b0cee31f","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"df2b7ca6-faa1-5155-b6f8-e38e875710a9","slug":"goals","fullItemName":"Goals"},{"id":"c88d8b1e-a003-5fdb-8125-60256108c8fd","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2381dd75-9264-51ce-923a-ffd47d06fb70","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9148277c-7b69-5abd-96e6-6da6cdc0692c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e337d403-433f-5884-ad90-0dc4725b9e10","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"98137183-55d3-54da-8a82-f70edd211099","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2308d842-41bc-5c6e-b14f-7a732380baae","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"25c232ac-1d36-5623-a083-670842228d71","slug":"definition","fullItemName":"Definition"},{"id":"d6bc684b-0cf9-51f4-880a-68386599241c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0baab6c3-f7e8-573b-96ee-4e51d9cb5330","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"8e6a2c35-a2df-5ed9-8430-1d28fa50879e","slug":"complications","fullItemName":"Complications"},{"id":"808d9af1-4926-59a3-80ef-e810780e9314","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"34a7e7aa-63d3-5df0-9b78-2d694441515e","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"0f83f809-aed6-51e2-990d-c63ccf224d4e","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"36a8ef6d-dd7b-5e24-88b6-2e0d2e428522","slug":"assessment","fullItemName":"Assessment"},{"id":"da38cadb-36b7-5e94-a4d2-1ac880a9fc14","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"512f5f04-323c-5417-9d49-118aaf08ef60","slug":"management","fullItemName":"Management","subChapters":[{"id":"e22f1fdc-9a01-51a6-9519-694c4dc68f3e","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"919d8121-c385-56c1-a44a-d1b60e0744d8","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"54149fa7-c48e-56d7-909c-d76fceaaa0b6","slug":"topical-imidazoles","fullItemName":"Topical imidazoles"},{"id":"3e0033c5-591d-5608-8277-0cb6706398f5","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"4a82e127-a2d6-5fae-9103-e83494a28d24","slug":"clarithromycin","fullItemName":"Clarithromycin"}]},{"id":"01431b56-1a68-53cb-9666-0bc883bec5ff","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"186815e3-961f-5ab5-b89d-b7d341d8851a","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"c9ab642f-9b46-54ff-a595-1e9168cbfdff","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a12c552f-6d1a-5409-a5cf-dc1efba7bb2a","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d9167d23-de60-534b-b0da-c093d3a37b23","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"33ede077-9ff7-58b7-981d-d4dd371561b0","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"db7928f1-0104-5ed1-8880-c59b9f060e6f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"96311897-ae0a-5de9-a6a0-0cb5e181a4d3","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"fced145b-8234-5cd6-8495-21dd435fa09e"}},"staticQueryHashes":["3666801979"]}